Update on once-daily zonisamide monotherapy in partial seizures

References

• SillsGBrodieMPharmacokinetics and drug interactions with zonisamideEpilepsia20074843544117319920
   PubMed Web of Science ®Google Scholar
• Zonegran® Prescribing Information2012 Available from: http://us.eisai.com/wps/wcm/connect/Eisai/Home/Our+Products/ZONEGRAN/Accessed November 30, 2013
   Google Scholar
• SeinoMLeppikIEZonisamideEngelJPedleyTAEpilepsy: A Comprehensive Text Book2nd edPhiladelphia, PA, USALippincott Williams and Wilkins2008
   Google Scholar
• Dainippon Pharmaceutical Co, LtdEisai conclude agreement for the development, manufacture and marketing of the anti-epileptic agent zonisamide in Asia2005 Available from: http://www.ds-pharma.com/news/prior/dainippon_2005/20050329.htmlAccessed November 30, 2013
   Google Scholar
• DupontSStefanHZonisamide in clinical practiceActa Neurol Scand Suppl2012194293523106523
   PubMedGoogle Scholar
• FrenchJAWangSWarnockBTemkinNHistorical control monotherapy design in the treatment of epilepsyEpilepsia2010511936194320561024
   PubMed Web of Science ®Google Scholar
• FrenchJATemkinNRShnekerBFHammerAECaldwellPTMessenheimerJALamotrigine XR conversion to monotherapy: first study using a historical control groupNeurotherapeutics2012917618422139591
   PubMed Web of Science ®Google Scholar
• UnoHKurokawaMMasudaYNishimuraHStudies on 3-substituted 1,2-benzisoxazole derivatives. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activitiesJ Med Chem197922180183423197
   PubMed Web of Science ®Google Scholar
• BrodieMJBen-MenachemEChouetteIGiorgiLZonisamide: its pharmacology, efficacy and safety in clinical trialsActa Neurol Scand Suppl2012194192823106522
   PubMedGoogle Scholar
• KochakGMPageJGBuchananRAPetersRPadgettCSSteady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizuresJ Clin Pharmacol1998381661719549648
   PubMed Web of Science ®Google Scholar
• ShahJShellenbergerKCanafaxDMZonisamide: chemistry, biotransformation, and pharmacokineticsLevyRHMattsonRHMeldrumBSPeruccaEAntiepileptic Drugs5th edPhiladelphia, PA, USALippincott Williams & Wilkins2002
   Google Scholar
• NewmarkMEDubinskySZonisamide monotherapy in multi-group clinicSeizure20041322322515121129
   PubMed Web of Science ®Google Scholar
• WilfongAAZonisamide monotherapy for epilepsy in children and young adultsPediatr Neurol200532778015664764
   PubMed Web of Science ®Google Scholar
• KimHLAldridgeJRhoJMClinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral centerJ Child Neurol20052021221915832611
   PubMed Web of Science ®Google Scholar
• KothareSVKaleyiasJMostofiNEfficacy and safety of zonisamide monotherapy in a cohort of children with epilepsyPediatric Neurol200634351354
   PubMed Web of Science ®Google Scholar
• ParkSPKimSYHwangYHSuhCKKwonSHLong term efficacy and safety of zonisamide monotherapy in epilepsy patientsJ Clin Neurol2007317518019513128
   PubMed Web of Science ®Google Scholar
• FujiiTFurukamaHMatsumotoKDainippon Pharmaceutical Co, Ltd, Developmental Laboratories. Data on file, 1989 Japanese
   Google Scholar
• KumagaiNSekiTYamawakiHMonotherapy for childhood epilepsies with zonisamideJpn J Psychiatry Neurol1991453573591762217
   PubMedGoogle Scholar
• HayakawaTNejihashiYKishiTSerum zonisamide concentration in fresh cases of childhood epilepsy following zonisamide monotherapyJ Jpn Epilepsy Soc199412249254 Japanese
   Google Scholar
• YagiKSekiTZonisamide in Epilepsy Therapy: Remarkable Improvement in 100 Cases1st edTokyo, JapanSozo Shuppan1994 Japanese
   Google Scholar
• MiuraHZonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studiesSeizure200413Suppl 1S17S2315511682
   PubMed Web of Science ®Google Scholar
• SekiTKumagaiNMaezawaMEffects of zonisamide monotherapy in children with epilepsySeizure200413Suppl 1S26S3215511685
   PubMed Web of Science ®Google Scholar
• EunSHKimHDEunBLComparative trial of low-and high-dose zonisamide as monotherapy for childhood epilepsySeizure20112055856321543239
   PubMed Web of Science ®Google Scholar
• BaulacMBrodieMJPattenASegiethJGiorgiLEfficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomized, double-blind, non-inferiority trialLancet Neurol20121157958822683226
   PubMed Web of Science ®Google Scholar
• TrinkaEGiorgiLPattenASegiethJSafety and tolerability of zonisamide in elderly patients with epilepsyActa Neurol Scand201312842242823773051
   PubMed Web of Science ®Google Scholar
• ToschesWATisdellJLong-term efficacy and safety of monotherapy and adjunctive therapy with zonisamideEpilepsy Behav2006852252616542880
   PubMed Web of Science ®Google Scholar
• FukushimaKSeinoMA long-term follow-up of zonisamide monotherapyEpilepsia2006471860186417116025
   PubMed Web of Science ®Google Scholar
• ParkSPHwangYHLeeHWSuhCKKwonSHLeeBILong-term cognitive and mood effects of zonisamide monotherapy in epilepsy patientsEpilepsy Behav20081210210817945539
   PubMed Web of Science ®Google Scholar
• BaulacMBagulMPattenAGiorgiLLong-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, multinational, randomized, double-blind, active-controlled studyEpilepsia201354Suppl 3S173
   Google Scholar
• KwanPBrodieMJEpilepsy after the first drug fails: substitution or add on?Seizure2000946446811034869
   PubMed Web of Science ®Google Scholar
• BrodieMJBarrySJBamagousGANorrieJDKwanPPatterns of treatment response in newly diagnosed epilepsyNeurology2012781548155422573629
   PubMed Web of Science ®Google Scholar
• KwanPSanderJWThe natural history of epilepsy: an epidemiological viewJ Neurol Neurosurg Psychiatry2004751376138115377680
   PubMed Web of Science ®Google Scholar
• CramerJAGlassmanMRienzaVThe relationship between poor medication compliance and seizuresEpilepsy Behav2002333834212609331
   PubMed Web of Science ®Google Scholar
• St LouisEKRosenfeldWEBramleyTAntiepileptic drug monotherapy: the initial approach in epilepsy managementCurr Neuropharmacol20097778219949565
   PubMed Web of Science ®Google Scholar
• UCB Media CenterUCB files VIMPAT® (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures2013 Available from: http://www.ucb.presscentre.com/News/UCB-files-VIMPAT-lacosamide-in-the-US-as-monotherapy-treatment-in-adult-epilepsy-patients-with-pa-46e.aspxAccessed November 30, 2013
   Google Scholar
• BrodieMJPeruccaERyvlinPBen-MenachemEMeenckeHJComparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsyNeurology20076840240817283312
   PubMed Web of Science ®Google Scholar
• KwanPBrodieMJKälviäinenRYurkewiczLWeaverJKnappLEEfficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomized, parallel group trialLancet Neurol20111088189021889410
   PubMed Web of Science ®Google Scholar
• GlauserTBen-MenachemEBourgeoisBUpdated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia20135455156323350722
   PubMed Web of Science ®Google Scholar